Navigation Links
Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2007
Date:11/6/2007

nd will also be used as a learning facility to train future operators of commercial plants for both Verenium and its technology licensees. The Company is on track to complete mechanical construction of the demonstration plant by the end of the first quarter of 2008.

Once mechanically complete, the demonstration plant will go through a comprehensive start-up phase to test the functional capabilities of the facility as well as evaluate the Verenium process at scale, including the ability to produce ethanol within predefined economic criteria. The first phase will be mechanically oriented, and will include: hydrostatic testing, testing all electrical systems, integrating enzymes and biology, and moving feedstock through the system. Next, the Company will begin a commissioning phase where process design will be evaluated at scale, ethanol will be produced, and variable-cost economics will be verified. Throughout this phase, the Company will continue to make process modifications and improvements. The final phase will be focused on optimizing the plant for continuous operation in the most cost-efficient manner. The Company expects that this entire start-up process will last between nine and twelve months. Over the course of this process, the demonstration plant is expected to produce important operating metrics that the Company expects to help drive the initiation of its commercial development plans.

Additional Biofuels Business Unit highlights for the third quarter include:

-- Critical R&D work at the pilot plant continues to further the Company's

understanding and know-how with regard to pre-treatment and production

economics. The Company expects that these key learnings will provide

for enhanced design optimization once the demonstration plant is

complete.

-- The Company's business development team significantly accelerated its

commercialization activities during the quarter in Louisiana, Florida'/>"/>

SOURCE Verenium Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...er & Olsen LLP has filed a,class action lawsuit ag..."Company") (Nasdaq: ARTC ) and certain of its off...istrict of Texas on behalf of all persons or,entit... January 24, 2008,through July 18, 2008 (the "Comm...or entities who purchased call options or sold put...
(Date:7/25/2008)... therapy may be due to genetic factors , ... challenges the long-held belief that the hepatiti...y to restore itself after HIV patients are treated.... , From 50 percent to 90 percent of HIV-infect...ous drug use is the main cause of both types of in...
(Date:7/25/2008)...ity.com announces the,availability of Trade Alerts... all of the daily trading notes for free by visiti...erts include: DUSA Pharmaceuticals Inc. (Nasdaq: ... MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp....) and,Abaxis Inc. (Nasdaq: ABAX )., Join investo...
(Date:7/25/2008)...mprovements in Members, Health, ATLANTA, July 25 ...h,care quality management solutions for health pla...nto a long-term agreement with Wellmark, Inc. to,c...lity(SM) Incent and,Reward Best Practices initiati...are clinicians to promote improved quality health ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...a spectacle when she had epileptic seizures, almos... her fit//, her face had a scowl and a guttural si...she convulsed. This had led her to be named as "T...en Schneider, of Schneider Children's Hospital in ...
...n recommended for medical conditions such as endom...estyle choice for women who dislike menstruation o...sion safe and is it a reasonable lifestyle choice,... Psychologist in this week’s BMJ? Birth control o...
... with lethal and disabling conditions is illegal w...ctice vary between different countries. An edito...e? In the Netherlands, about 200,000 live births ...0-20 babies – mostly with severe congenital malfor...
...roats may benefit from having a tonsillectomy in t... is// still unclear, and any benefits have to be b... A small study of adults from Finland showed tha...the likelihood of further infection after 90 days,...
Other Medicine News:Health News:Should Menstrual Suppression Be a Lifestyle Choice? 2Health News:Should the UK Adopt Dutch Rules on Euthanasia in Newborn Babies? 2Health News:Is It Worth Having Surgery to Remove Your Tonsils? 2
(Date:7/24/2008)...wswire/ -- Headlines claiming "soy,products lower ...l scale,preliminary study that Dr. Jorge Chavarro... on recollected intake of soyfoods and not on,spec...founded by many,issues, thus I feel the results sh...ed Dr. Tammy Hedlund, a researcher in prostate can...
(Date:7/23/2008)... Therapy to Treat the Disease -, WAYNE, N.J. and ... --,Bayer HealthCare Pharmaceuticals and Onyx Phar...hat The New England Journal of Medicine published,...var(R) (sorafenib),tablets decreased the absolute ...ectable hepatocellular carcinoma (HCC), or liver c...
(Date:7/23/2008)...ody Have Greater Concentrations of,Stem Cells, AR...ire/ -- Fat removed,from the lower abdomen and inn...cellent source of stem cells, with higher stem cel...orts a Brazilian-based study in August,s,Plastic a... journal of the,American Society of Plastic Surgeo...
(Date:7/22/2008)...ti-center 293-patient European, trial -, http:/...: CYT, MONTREAL, July 22 /...in cryotherapy products to treat cardiac,arrhythmi...ted from three,European study centers using the Co...hed earlier today in the Journal of the American C...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Modigene to Present at the Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5448 1First Use in a Patient of The InfraReDx LipiScan 28TM 29 Coronary Imaging System 2081 1First Use in a Patient of The InfraReDx LipiScan 28TM 29 Coronary Imaging System 2081 2First Use in a Patient of The InfraReDx LipiScan 28TM 29 Coronary Imaging System 2081 3First Use in a Patient of The InfraReDx LipiScan 28TM 29 Coronary Imaging System 2081 4CDC Recommends Shingles Vaccine for Those Over 60 19501 1CDC Recommends Shingles Vaccine for Those Over 60 19501 2CDC Recommends Shingles Vaccine for Those Over 60 19501 3Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 1Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 2Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 3
...)--Jul 3, 2007 - Nymox,Pharmaceutical Corporation ...al results from the Company,s studies of NX-1207 f...ented at the New,England Section of the American U...er. The paper is authored by leading clinical,rese...-107., The Company previously completed three U.S....
...swire-FirstCall/ --,Genzyme Corp. today announced ...g the safety and efficacy of hylastan in treating ...nee. Hylastan is being,developed within Genzyme,s ...t that can be delivered through a single,knee inje...ain,management, reduce the overall cost of therapy...
Other Medicine Technology:Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2Genzyme Announces Results of Clinical Trial of Hylastan 2Genzyme Announces Results of Clinical Trial of Hylastan 3Genzyme Announces Results of Clinical Trial of Hylastan 4
...Flex video magnifier (model CLAF) consists of an e...attached to a 14" arm that is mounted on an xY tab...iting and doing hobbies and crafts. It comes with... so that you can easily move the table side to sid...
Flipper's innovative rotating camera design enables people with low vision to perform daily tasks more effectively. By rotating the camera head, the user can read, write, and view magnified images at
...al purpose incubators designed to provide the prec...r the most demanding incubation applications. Thes...eature push-button temperature setpoint selection,...r-temperature protection. Equally important, the s...
...onomy Incubators available in five different model...ties of 1.4 cu. Ft. (39 liters), 2.5 cu. Ft. (71.5...rtant, Precision Economy Incubators combine a wide...itivity, stability, and uniformity. As a result, y...
Medicine Products: